Foreign -funded pharmaceutical giants fight for China's tens of billions of drop sugar market
Release time: 2010-04-07 stake betting app& nbsp & nbsp & nbsp Source:
stake sports betting appOn the diabetic drug market in China，Competition between foreign -funded giants has begun to increase，The newcomer is growing。Current，Novo and Nord、Lilly Lili、Sanofi-Avant three multinational pharmaceutical companies occupy nearly 90%of the number of hypoglycemic medications in Tanqian hospitals。
and the State Food and Drug Administration (SFDA) Southern Medical Economics Institute's monitoring data on the domestic hypoglycemic market display，2008，The national anti -diabetic medication market has reached 8.52 billion yuan; according to the natural growth of domestic diabetes and changes in the structure of drug use，to 2012，This market share will increase more than 3 times compared to the current。
To compete for this growing huge market，Both the newcomers Stake Sports Bettingand stake betting appthe traditional giants are constantly adding codes。
A few days ago，Merhadon announced that SFDA officially approved its type of hypoglycemic new drugs in China，Merhadon's confidence in the drug's performance in the Chinese market，Janovo achieved global sales of $ 760 million in the fourth quarter of last year，increased by 43%year -on -year。Nuo and Nord announcement pointed out，Its original drug Victoza (Liculatin), which is used in the treatment of adult type II diabetes, will be officially locked in China at the end of 2010 at the end of 2010。Almost at the same time，Lilio's new type of diabetes new product Ohda officially landed on the Chinese market。
To further expand its market share in China，Sanofi Avant announced an increase of 600 million yuan in investment to the Chinese market，Expanded stake betting appStake Sports Bettinginsulin factories located in the Beijing Economic and Technological Development Zone; Novo and Noord spent nearly $ 400 million in Tianjin to establish the world's largest insulin preparation and filling factory，Announced that it cooperates with the Shanghai Academy of Life Sciences of the Chinese Academy of Sciences to establish a preliminary transformation research center of diabetes;。
and the State Food and Drug Administration (SFDA) Southern Medical Economics Institute's monitoring data on the domestic hypoglycemic market display，2008，The national anti -diabetic medication market has reached 8.52 billion yuan; according to the natural growth of domestic diabetes and changes in the structure of drug use，to 2012，This market share will increase more than 3 times compared to the current。
To compete for this growing huge market，Both the newcomers Stake Sports Bettingand stake betting appthe traditional giants are constantly adding codes。
A few days ago，Merhadon announced that SFDA officially approved its type of hypoglycemic new drugs in China，Merhadon's confidence in the drug's performance in the Chinese market，Janovo achieved global sales of $ 760 million in the fourth quarter of last year，increased by 43%year -on -year。Nuo and Nord announcement pointed out，Its original drug Victoza (Liculatin), which is used in the treatment of adult type II diabetes, will be officially locked in China at the end of 2010 at the end of 2010。Almost at the same time，Lilio's new type of diabetes new product Ohda officially landed on the Chinese market。
To further expand its market share in China，Sanofi Avant announced an increase of 600 million yuan in investment to the Chinese market，Expanded stake betting appStake Sports Bettinginsulin factories located in the Beijing Economic and Technological Development Zone; Novo and Noord spent nearly $ 400 million in Tianjin to establish the world's largest insulin preparation and filling factory，Announced that it cooperates with the Shanghai Academy of Life Sciences of the Chinese Academy of Sciences to establish a preliminary transformation research center of diabetes;。
